• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALL
Click for more information
1.42% 13,523

NZX All

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.

See All Discussions arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
(20min delay)
Last
13,523 		Change
-194.720(1.42%) 		Mkt cap ! n/a
Open High Low
13,717 13,717 13,523
ALL (NZSX) Chart

Top Stories

Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs

Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.